Hawks, Z. W. http://orcid.org/0000-0002-3796-0289
Beck, E. D. http://orcid.org/0000-0002-8152-3510
Jung, L.
Fonseca, L. M. http://orcid.org/0000-0002-2849-0545
Sliwinski, M. J.
Weinstock, R. S. http://orcid.org/0000-0001-5859-5666
Grinspoon, E. http://orcid.org/0000-0002-5608-8254
Xu, I.
Strong, R. W.
Singh, S.
Van Dongen, H. P. A. http://orcid.org/0000-0002-4678-2971
Frumkin, M. R. http://orcid.org/0000-0002-3122-4483
Bulger, J.
Cleveland, M. J.
Janess, K.
Kudva, Y. C. http://orcid.org/0000-0003-0285-6622
Pratley, R.
Rickels, M. R.
Rizvi, S. R. http://orcid.org/0000-0002-2607-4812
Chaytor, N. S. http://orcid.org/0000-0001-8821-289X
Germine, L. T.
Article History
Received: 13 March 2023
Accepted: 14 February 2024
First Online: 18 March 2024
Competing interests
: LG is on the Board of Directors of the Many Brains Project, a 501c3 nonprofit organization that disseminates cognitive tests. NC is a paid consultant for Adaptelligence, LLC. ZWH and MRF have received consulting fees from Blueprint Health. SS has received consulting fees from Aphelion Capital. RSW has participated in multicenter clinical trials through her institution sponsored by Eli Lilly Novo Nordisk, Insulet, Tandem, Amgen, MannKind and Diasome and has used devices donated by DexCom in research studies. YCK has had product support from Dexcom Inc. and Tandem Inc., is on an advisory board for Novo Nordisk, USA, and has participated in multicenter clinical trials through his institution funded by Dexcom, Tandem, Medtronic and Mannkind. HVD is a paid consultant for Jazz Pharmaceuticals. The authors declare no other competing interests.